This study identified key molecular changes in schizophrenia, notably the upregulation of S100A8, S100A9 and BCL2A1 and thedownregulation of CBLB, highlighting the involvement of neuro-inflammatory pathways, apoptosis regulation and immune modulation in thedisease. This evidence concerns the gene BCL2A1 and schizophrenia.